TLR9 expression and its role in chemosensitivity to DDP in human cervical cancer cells in vitro
详细信息 查看全文
- 作者：Yanjie Weng (1)
Yongjun Wang (1) (2)
Ying Shi (1)
Wenjuan Zhou (1)
Hongyan Wang (1)
Changyu Wang (1) - 关键词：cervical cancer ; Toll ; like receptor 9 ; cisplatin ; HPV infection
- 刊名：Journal of Huazhong University of Science and Technology [Medical Sciences]
- 出版年：2011
- 出版时间：August 2011
- 年：2011
- 卷：31
- 期：4
- 页码：550-554
- 全文大小：427KB
- 参考文献：1. Jemal A, Bray F, Center MM, / et al. Global cancer statistics. CA Cancer J Clin, 2011,61(2):69-0 CrossRef
2. Schwarz E, Freese UK, Gissmann L, / et al. Structure and Transcription of Human Papillomavirus Sequences in Cervical-Carcinoma Cells. Nature, 1985,314(6006):111-14 CrossRef
3. Nikolaitchouk N, Andersch B, Falsen E, / et al. The lower genital tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH). APMIS, 2008,116(4): 263-77 CrossRef
4. Hari A, Flach TL, Shi Y, / et al. Toll-like receptors: role in dermatological disease. Mediators Inflamm, 2010,2010: 437246 CrossRef
5. McInturff JE, Modlin RL, Kim J. The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J Inv Dermatol, 2005,125(1):1- CrossRef
6. Yu L, Chen SW. Toll-like receptors expressed in tumor cells: targets for therapy. Cancer Immunol Immunother, 2008,57(9):1271-278 CrossRef
7. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell, 2006,124(4):783-01 CrossRef
8. Medzhitov R, Janeway C. Innate immunity. N Engl J Med, 2000,343(5):338-44 CrossRef
9. Poltorak A, He X, Smirnova I, / et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in TLR4 gene. Science, 1998,282(5396):2085-088 CrossRef
10. Hayashi F, Smith KD, Ozinsky A, / et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature, 2001,410(6832):1099-103 CrossRef
11. Lee JW, Choi JJ, Seo ES, / et al. Increased toll-like receptor 9 expression in cervical neoplasia. Mol Carcinog, 2007,46(11):941-47 CrossRef
12. Wang W, Wang S, Song X, / et al. The relationship between c-FLIP expression and human papillomavirus E2 gene disruption in cervical carcinogenesis. Gynecol Oncol, 2007,105(3):571-77 CrossRef
13. Weng D, Song X, Xing H, / et al. Implication of the Akt2/survivin pathway as a critical target in paclitaxel treatment in human ovarian cancer cells. Cancer Letters, 2009,273(2):257-65 CrossRef
14. Wu H, Cao Y, Weng D, / et al. Effect of tumor suppressor gene PTEN on the resistance to cisplatin in human ovarian cancer cell lines and related mechanisms. Cancer Letters, 2008,271(2):260-71 CrossRef
15. Pisani P, Parkin DM, Bray F, / et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer, 1999,83(1):18-9 CrossRef
16. Bosch FX, Lorincz A, Munoz N, / et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol, 2002,55(4):244-65 CrossRef
17. Munoz N, Bosch FX, de Sanjose S, / et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 2003,348(6):518-27 CrossRef
18. Huang B, Zhao J, Li HX, / et al. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res, 2005,65(12):5009-014 CrossRef
19. Goto Y, Arigami T, Kitago M, / et al. Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors. Mol Cancer Ther, 2008,7(11):3642-653 CrossRef
20. Andersen JM, Al-Khairy D, Ingalls RR. Innate immunity at the mucosal surface: Role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens. Biol Reprod, 2006,74(5):824-31 CrossRef
21. Modlin RL, Cheng G. From plankton to pathogen recognition. Nat Med, 2004,10(11):1173-174 CrossRef
22. Matsushima H, Yamada N, Matsue H, / et al. TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skinderived mast cells but not from bone marrow-derived mast cells. J Immunol, 2004,173(1):531-41
23. Yu L, Wang L, Li M, / et al. Expression of toll-like receptor 4 is down-regulated during progression of cervical neoplasia. Cancer Immunol Immunother, 2010,59(7): 1021-028 CrossRef
24. Chow EK, O’connell RM, Schilling S, / et al. TLR agonists regulate PDGF-B production and cell proliferation through TGF-b/type I IFN crosstalk. EMBO J, 2005, 24(23):4071-081 CrossRef
25. Hasan UA, Bates E, Takeshita F, / et al. TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16. J Immunol, 2007,178(5):3186-197
26. Martin M, Rehani K, Jope RS, / et al. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nature Immunol, 2005,6(8):777-84 CrossRef
27. Ivanov S, Dragoi AM, Wang X, / et al. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood, 2007,110(6):1970-981 CrossRef - 作者单位：Yanjie Weng (1)
Yongjun Wang (1) (2)
Ying Shi (1)
Wenjuan Zhou (1)
Hongyan Wang (1)
Changyu Wang (1)
1. Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China
2. Minimally Invasive Center of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, 10010, China
文摘